Experientia

, Volume 51, Issue 3, pp 230–234 | Cite as

Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin: Cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats

  • K. M. Wasan
  • V. B. GrossieJr
Research Articles
  • 41 Downloads

Abstract

We compared the effects of 0.45% normal saline (NS), 5% Intralipid® (IL), and 16.7% glucose (Glu) infusions on total serum triglycerides and cholesterol, serum high-(HDL-c) and low-density lipoprotein cholesterol (LDL-c), and activity of serum lecithin: cholesterol acyltransferase (LCAT), and serum lipoprotein lipase (LPL) in rats implanted with a fibrosarcoma. In tumor-bearing rats given NS, a two-fold increase in total serum cholesterol, a four-fold increase in LDL-c, and a five-fold decrease in the HDL-c/LDL-c ratio were observed compared to tumor-free rats. In tumor-bearing rats administered IL, a two-fold increase in total serum triglyceride and cholesterol, a three-fold increase in HDL-c and HDL-c/LDL-c ratio, and a two-fold increase in LPL activity were observed compared to tumor-bearing rats administered NS. In tumor-bearing rats administered Glu, a two-fold decrease in total serum cholesterol, a two-fold decrease in HDL-c, and a three-fold decrease in LDL-c were observed compared to tumor-bearing rats administered NS. Tumor weights and LCAT activity did not differ significantly between treatment groups. Previous results have demonstrated that lipophilic compounds that interact with plasma lipoproteins have altered pharmacological effects when administered with IL. Therefore, this study suggests that IL infusions alter the HDL-c/LDL-c ratio and could affect the pharmacological behavior of anticancer compounds that predominantly distribute into the LDL fraction upon entrance into the bloodstream.

Key words

Intralipid lipoproteins fibrosarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hultin, M., Bengtsson-Olivecronia, G., and Olivecronia, T., Biochim. biophys. Acta1125 (1992) 97.PubMedGoogle Scholar
  2. 2.
    Griffin, E., Breckenridge, W. C., Kuksis, A., Bryan, M. H., and Angel, A., J. clin. Invest.64 (1979) 1703.PubMedGoogle Scholar
  3. 3.
    Breckenridge, W. C., Kakis, G., and Kuksis, A., Can. J. Biochem.57 (1979) 72.PubMedGoogle Scholar
  4. 4.
    Untracht, S. H., Biochim. biophys. Acta711 (1982) 176.PubMedGoogle Scholar
  5. 5.
    Tashiro, T., Mashima, Y., Yamamori, H., Horibe, K., Nishizawa, M., Sanada, M., and Okui, K., J. parental ent. Nutr.15 (1991) 546.Google Scholar
  6. 6.
    Wasan, K. M., Grossie, V. B., and Lopez-Berestein, G., Lab. Anim.28 (1994) 138.PubMedGoogle Scholar
  7. 7.
    Gueddari, N., Favre, G., Hachem, H., Marek, E., Gaillard, F. L., and Soula, G., Biochimie75 (1993) 811.CrossRefPubMedGoogle Scholar
  8. 8.
    Vitols, S., Angelin, B., Ericsson, S., Gahrton, G., Juliusson, G., Masquelier, M., Paul, C., Peterson, C., Rudling, M., Soderberg-Ried, K., and Tidefelt, U., Proc. natl Acad. Sci. USA87 (1990) 2598.PubMedGoogle Scholar
  9. 9.
    Vitols, S., Gahrton, G., Ost, A., and Peterson, C., Blood63 (1984) 1186.PubMedGoogle Scholar
  10. 10.
    Ho, Y. K., Smith, R. G., Brown, M. S., and Goldstein, J. L., Blood52 (1978) 1099.PubMedGoogle Scholar
  11. 11.
    Hynds, S. A., Welsh, J., Stewart, J. M., Jack, A., Soukop, M., Mcardle, C. S., Calman, K. C., Packard, C. J., and Shepherd, J., Biochim. biophys. Acta795 (1984) 589.PubMedGoogle Scholar
  12. 12.
    Vitols, S., Gahrton, G., Bjorkholm, M., and Peterson, C., Lancetiv (1985) 1150.CrossRefGoogle Scholar
  13. 13.
    Budd, D., and Ginsberg, H., Cancer58 (1986) 1361.PubMedGoogle Scholar
  14. 14.
    Alexopoulos, C. G., Blatsios, B., and Avgerinos, A., Cancer60 (1987) 3065.PubMedGoogle Scholar
  15. 15.
    Joly, V., Farinotti, R., Saint-Julien, L., Cheron, M., Carbon, C., and Yeni, P., Antimicrob. Ag. Chemother.38 (1994) 177.Google Scholar
  16. 16.
    Kirsh, R., Goldstain, R., Tarloff, J., Parris, D., Hook, J., and Hanna, N., J. infect. Dis.158 (1988) 1065.PubMedGoogle Scholar
  17. 17.
    Moreau, P., Milpied, N., Fayette, N., Ramee, J. F., and Harousseau, J. L., J. antimicrob. Chemother30 (1992) 535.PubMedGoogle Scholar
  18. 18.
    Venkataram, S., Awni, W. M., Jordan, K., and Rahman, Y. E., J. pharm. Sci.79 (1990) 216.PubMedGoogle Scholar
  19. 19.
    Grossie, V. B., Nishioka, K., Ota, D. M., and Martin, R. G., Cancer Res.46 (1986) 3463.Google Scholar
  20. 20.
    Steiger, E., Vars, E. M., and Dudrick, S. J., Archs. Surg.104 (1972) 330.Google Scholar
  21. 21.
    Turco, S., and King, R. E., in: Sterile Dosage Forms, Their Preparation and Clinical Application, 3rd edn, p. 120. Eds S. Turco and R. E. King, Lea and Febiger, Philadelphia, PA, USA, 1987.Google Scholar
  22. 22.
    Wasan, K. M., Brazeau, G. A., Keyhani, A., Hayman, A. C., and Lopez-Berestein, G., Antimicrob. Ag. Chemother.37 (1993) 246.Google Scholar
  23. 23.
    Albers, J. J., Chen, C. H., and Lacko, A. G., Meth. Enzym.129 (1986) 763.PubMedGoogle Scholar
  24. 24.
    Iverius, P., and Ostlund-Lindqvist, A. M., Meth. Enzym.129 (1986) 691.PubMedGoogle Scholar
  25. 25.
    Zar, J. H., Biostatistical Analysis, 2nd edn. Prentice-Hall International, Englewood Cliffs, N.J., 1984.Google Scholar
  26. 26.
    Weinberg, R. B., and Singh, K., Am. J. clin. Nutr.49 (1989) 794.PubMedGoogle Scholar
  27. 27.
    Hajri, T., Ferezou, J., and Lutton, C., Biochim. biophys. Acta1047 (1990) 121.PubMedGoogle Scholar
  28. 28.
    Hajri, T., Ferezou, J., Steinmetz, P., and Lutton, C., Biochim. biophys. Acta1166 (1993) 84.PubMedGoogle Scholar
  29. 29.
    Ney, D. M., Yang, H., Rivera, J., and Lasekan, J. B., J. Nutr.123 (1993) 883.PubMedGoogle Scholar
  30. 30.
    Amr, S., Hamosh, P., and Hamosh, M., Biochim. biophys. Acta1001 (1989) 145.PubMedGoogle Scholar
  31. 31.
    Jonas, A., Biochim. biophys. Acta1084 (1991) 205.PubMedGoogle Scholar
  32. 32.
    Ginsburg, B. E., and Zetterstrom, R., Acta paediat. scand.66 (1977) 39.PubMedGoogle Scholar
  33. 33.
    Peterson, J., Bihain, B. E., Bengtsson-Olivecronia, G., Deckelbaum, R. J., Carpentier, Y. A., and Olivecronia, T., Proc. natl Acad. Sci. USA87 (1990) 909.PubMedGoogle Scholar
  34. 34.
    Bayerdorffer, E., Mannes, G. A., Richter, W. O., Ochsenkuhn, T., Seeholzer, G., Kopcke, W., Wiebecke, B., and Paumgartner, G., Ann. inter. Med.118 (1993) 481.Google Scholar
  35. 35.
    Kritchevsky, S. B., Wilcosky, T. C., Morris, D. L., Troung, K. N., and Tyroler, H. A., Cancer Res.51 (1991) 3198.PubMedGoogle Scholar
  36. 36.
    Davey-Smith, G., Shipley, M. J., Marriot, M. G., and Rose, G., J. Am. med. Assoc.267 (1992) 70.CrossRefGoogle Scholar
  37. 37.
    Wasan, K. M., Grossie, V. B., and Lopez-Berestein, G., Antimicrob. Ag. Chemother.38 (1994) 2224.Google Scholar
  38. 38.
    Wasan, K. M., Drugs of the Future19 (1994) 225.Google Scholar
  39. 39.
    Wasan, K. M., Rosenblum, M. G., Cheung, L., and Lopez-Berestein, G., Antimicrob. Ag. Chemother.38 (1994) 223.Google Scholar

Copyright information

© Birkhäuser Verlag Basel 1995

Authors and Affiliations

  • K. M. Wasan
    • 1
  • V. B. GrossieJr
    • 2
  1. 1.Faculty of Pharmaceutical SciencesUniversity of British ColumbiaVancouverCanada
  2. 2.Department of Surgical OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations